Wealthfront Advisers LLC
- SEC CIK
- 0001763921
- Latest filing
- Aug 7, 2026
ALNY holding history
Alnylam Pharmaceuticals, Inc. in every 13F filed by Wealthfront Advisers LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings
- Shares (Q2 2026)
- 9,554
- Value
- $2.88M
- % of portfolio
- <0.1%
- Quarters held
- 19
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 9,554 | $2.88M | <0.1% | −2,033−17.5% | Reduced | Holders |
| Q1 2026 | 11,587 | $3.83M | <0.1% | −6,667−36.5% | Reduced | Holders |
| Q4 2025 | 18,254 | $7.26M | <0.1% | +4,834+36.0% | Added | Holders |
| Q3 2025 | 13,420 | $6.12M | <0.1% | +1,336+11.1% | Added | Holders |
| Q2 2025 | 12,084 | $3.94M | <0.1% | +3,363+38.6% | Added | Holders |
| Q1 2025 | 8,721 | $2.35M | <0.1% | −3,899−30.9% | Reduced | Holders |
| Q4 2024 | 12,620 | $2.97M | <0.1% | +4,324+52.1% | Added | Holders |
| Q3 2024 | 8,296 | $2.28M | <0.1% | +200+2.5% | Added | Holders |
| Q2 2024 | 8,096 | $1.97M | <0.1% | +6+0.1% | Added | Holders |
| Q1 2024 | 8,090 | $1.21M | <0.1% | −3,495−30.2% | Reduced | Holders |
| Q4 2023 | 11,585 | $2.22M | <0.1% | −772−6.2% | Reduced | Holders |
| Q3 2023 | 12,357 | $2.19M | <0.1% | −15,289−55.3% | Reduced | Holders |
| Q2 2023 | 27,646 | $5.25M | <0.1% | −6,667−19.4% | Reduced | Holders |
| Q1 2023 | 34,313 | $6.87M | <0.1% | +1,727+5.3% | Added | Holders |
| Q4 2022 | 32,586 | $7.74M | <0.1% | +14,210+77.3% | Added | Holders |
| Q3 2022 | 18,376 | $3.68M | <0.1% | +4,258+30.2% | Added | Holders |
| Q2 2022 | 14,118 | $2.06M | <0.1% | +1,273+9.9% | Added | Holders |
| Q1 2022 | 12,845 | $2.10M | <0.1% | +11,526+873.8% | Added | Holders |
| Q4 2021 | 1,319 | $224.0K | <0.1% | +1,319 | New | Holders |